The European Granulomatous-Lymphocytic Interstitial Lung Disease Network (eGLILDnet) has developed a short survey to learn what ‘unanswered questions’ you have about GLILD. These are questions that you have not been able to have answered at all or to a level that you found helpful. This will help researchers to understand what areas need to be researched the most and what is most important to you as somebody who has been affected by GLILD. This means that the information you provide can help to improve the care and lives of those affected by GLILD.
Who can take part?
Closing date: 14 September at 09:00 CEST.
The survey is available in 8 languages:
Who are eGLILDnet?
eGLILDnet is a collaboration of clinicians and scientists from across Europe who are dedicated to improving the lives of those living with GLILD. The teams include members from: The European Respiratory Society (ERS), the European Society for Immunodeficiencies (ESID), the International Patient Organisation for Primary Immunodeficiencies (IPOPI) and ELF.
If you are interested in more information about e-GLILDnet or would like to join the registry, please contact email@example.com
Follow the progress of e-GLILDnet on twitter: @glildnet
Learn about the factors that can cause lung disease and the ways to reduce your contact with them.
Sign up to our free monthly newsletter to get the latest information and research news on lung conditions, plus views from experts and patients! You can unsubscribe at any time.